Recombinant Mouse Caspase-3/CASP3 Protein，His

Caspase-3, also known as CASP3, is a crucial cysteine protease that plays a key role in the execution phase of apoptosis, or programmed cell death. Its activation is a critical step in various cellular processes, including the response to stress, development, and immune regulation. Dysregulation of Caspase-3 activity has been implicated in numerous diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases, making it a significant focus of biomedical research. The study of recombinant Caspase-3 proteins allows researchers to better understand the molecular mechanisms underlying its activation and regulation. By producing and purifying CASP3 in a recombinant form, scientists can analyze its enzymatic properties, substrate specificity, and interactions with other proteins. This research not only contributes to our understanding of apoptotic pathways but also aids in the development of potential therapeutic strategies that can modulate Caspase-3 activity. Additionally, recombinant Caspase-3 can serve as a valuable tool for drug screening and the identification of novel small molecules that can either inhibit or enhance its activity, further advancing the field of targeted therapies in diseases characterized by aberrant apoptotic signaling. Overall, the investigation of Caspase-3 through recombinant protein studies is essential for elucidating its role in health and disease, with potential applications in improving clinical outcomes for various conditions associated with apoptosis dysregulation.